Growing old with cystic fibrosis - The characteristics of long-term survivors of cystic fibrosis

Respiratory Medicine

Volumn 103, Issue 4, 2009, Pages 629-635

  Simmonds, Nicholas J ^a   Cullinan, Paul ^a   Hodson, Margaret E ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Ageing; Cystic fibrosis; Longevity; Survival

Indexed keywords

ADULT; AGED; ALLELE; ARTICLE; BACTERIAL COLONIZATION; BODY MASS; BRONCHOPULMONARY ASPERGILLOMA; CONTROLLED STUDY; CYSTIC FIBROSIS; FEMALE; GENE MUTATION; GENOTYPE; HOSPITAL ADMISSION; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PANCREAS INSUFFICIENCY; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STENOTROPHOMONAS MALTOPHILIA; COMORBIDITY; FORCED EXPIRATORY VOLUME; GENETICS; MICROBIOLOGY; MIDDLE AGED; ONSET AGE; SPUTUM; STATISTICS AND NUMERICAL DATA; SURVIVOR; UNITED KINGDOM; UNITED STATES; VITAL CAPACITY; YOUNG ADULT;

ADULT; AGE OF ONSET; AGED; BODY MASS INDEX; COMORBIDITY; CYSTIC FIBROSIS; FEMALE; FORCED EXPIRATORY VOLUME; GREAT BRITAIN; HUMANS; LONDON; MALE; MIDDLE AGED; SPUTUM; SURVIVORS; UNITED STATES; VITAL CAPACITY; YOUNG ADULT;

EID: 60649115622     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2008.10.011     Document Type: Article

References (30)

1. Anderson D.H. Cystic fibrosis of the pancreas and its relation to celiac disease. A clinical and pathological study. Arch Dis Child 56 (1938) 344-399
2. Cystic Fibrosis Foundation. Patient registry 2005 annual data report (2006), Cystic Fibrosis Foundation, Bethesda, MD
3. Dodge J.A., Lewis P.A., Stanton M., and Wilsher J. Cystic fibrosis mortality and survival in the UK: 1947-2003. Eur Respir J 29 (2007) 522-526
4. UK Cystic Fibrosis Database. Annual Data Report 2003 (2005), University of Dundee
5. Schechter M.S. Non-genetic influences on cystic fibrosis lung disease: the role of sociodemographic characteristics, environmental exposures, and healthcare interventions. Semin Respir Crit Care Med 24 (2003) 639-652
6. De Boeck K., Wilschanski M., Castellani C., et al. Cystic fibrosis: terminology and diagnostic algorithms. Thorax 61 (2006) 627-635
7. Widerman E., Millner L., Sexauer W., and Fiel S. Health status and sociodemographic characteristics of adults receiving a cystic fibrosis diagnosis after age 18 years. Chest 118 (2000) 427-433
8. Gilljam M., Ellis L., Corey M., Zielenski J., Durie P., and Tullis D.E. Clinical manifestations of cystic fibrosis among patients with diagnosis in adulthood. Chest 126 (2004) 1215-1224
9. Gan K.H., Geus W.P., Bakker W., Lamers C.B., and Heijerman H.G. Genetic and clinical features of patients with cystic fibrosis diagnosed after the age of 16 years. Thorax 50 (1995) 1301-1304
10. Hunt B., and Geddes D.M. Newly diagnosed cystic fibrosis in middle and later life. Thorax 40 (1985) 23-26
11. Sanders J.S., Pryor T.D., and Wedel M.K. Prolonged survival in an adult with cystic fibrosis. Chest 77 (1980) 226-227
12. Rodman D.M., Polis J.M., Heltshe S.L., et al. Late diagnosis defines a unique population of long-term survivors of cystic fibrosis. Am J Respir Crit Care Med 171 (2005) 621-626
13. Cystic Fibrosis Foundation. Patient Registry 2003 Annual Data Report (2004) Bethesda, Maryland
14. Gibson G.J. Standardised lung function testing. Eur Respir J 6 (1993) 155-157
15. Elborn J.S., Shale D.J., and Britton J.R. Cystic fibrosis: current survival and population estimates to the year 2000. Thorax 46 (1991) 881-885
16. Correlation between genotype and phenotype in patients with cystic fibrosis. The cystic fibrosis genotype-phenotype consortium. N Engl J Med 329 (1993) 1308-1313
17. Emerson J., Rosenfeld M., McNamara S., Ramsey B., and Gibson R.L. Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis. Pediatr Pulmonol 34 (2002) 91-100
18. Parad R.B., Gerard C.J., Zurakowski D., Nichols D.P., and Pier G.B. Pulmonary outcome in cystic fibrosis is influenced primarily by mucoid Pseudomonas aeruginosa infection and immune status and only modestly by genotype. Infect Immun 67 (1999) 4744-4750
19. Aebi C., Bracher R., Liechti-Gallati S., Tschappeler H., Rudeberg A., and Kraemer R. The age at onset of chronic Pseudomonas aeruginosa colonization in cystic fibrosis - prognostic significance. Eur J Pediatr 154 (1995) S69-S73
20. Demko C.A., Byard P.J., and Davis P.B. Gender differences in cystic fibrosis: Pseudomonas aeruginosa infection. J Clin Epidemiol 48 (1995) 1041-1049
21. Ericsson-Hollsing A. Serological markers of pulmonary infection in patients with cystic fibrosis (1987) Stockholm
22. Miall L.S., McGinley N.T., Brownlee K.G., and Conway S.P. Methicillin resistant Staphylococcus aureus (MRSA) infection in cystic fibrosis. Arch Dis Child 84 (2001) 160-162
23. Thomas S.R., Gyi K.M., Gaya H., and Hodson M.E. Methicillin-resistant Staphylococcus aureus: impact at a national cystic fibrosis centre. J Hosp Infect 40 (1998) 203-209
24. Steinkamp G., Wiedemann B., Rietschel E., et al. Prospective evaluation of emerging bacteria in cystic fibrosis. J Cyst Fibros 4 (2005) 41-48
25. Moran A., Doherty L., Wang X., and Thomas W. Abnormal glucose metabolism in cystic fibrosis. J Pediatr 133 (1998) 10-17
26. Moran A., Hardin D., Rodman D., et al. Diagnosis, screening and management of cystic fibrosis related diabetes mellitus: a consensus conference report. Diabetes Res Clin Pract 45 (1999) 61-73
27. Lanng S., Hansen A., Thorsteinsson B., Nerup J., and Koch C. Glucose tolerance in patients with cystic fibrosis: five year prospective study. BMJ 311 (1995) 655-659
28. Finkelstein S.M., Wielinski C.L., Elliott G.R., et al. Diabetes mellitus associated with cystic fibrosis. J Pediatr 112 (1988) 373-377
29. Milla C.E., Billings J., and Moran A. Diabetes is associated with dramatically decreased survival in female but not male subjects with cystic fibrosis. Diabetes Care 28 (2005) 2141-2144
30. Flume P.A., Strange C., Ye X., Ebeling M., Hulsey T., and Clark L.L. Pneumothorax in cystic fibrosis. Chest 128 (2005) 720-728